Here are relevant reports on : usb-power-delivery-market
-
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
- Published: April 2013
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
Learning Management System Market by Delivery Mode (Distance Learning, Instructor-led Learning, Blended Learning), Application Area (Corporate Training & Development, Professional Certification & Compliance, Course Management) - Global Forecast to 2032
The learning management system market is projected to reach 100.70 billion at a CAGR of 18.4% during the forecast period. The Key Players Anthology (US), Moodle (Australia), Cornerstone OnDemand (US), D2L Corporation (Canada), Instructure Inc. (US), PowerSchool (US), IBM (US), Infor (US), Adobe (US), LTG (UK), Google (US), Oracle (US), SAP (Germany), Docebo (Canada), Learning Pool (UK), Absorb LMS (Canada), CrossKnowledge (France), BizLibrary(US), iSpring (US), Blue Sky eLearn (US), Trakstar (US), DigitalChalk (US), Touvti LMS (US), SkyPrep (Canada), Talent LMS (US), Acorn LMS (Australia), and LearnWorlds (UK).
- Published: January 2026
- Price: $ 7150
- TOC Available:
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application [Diagnostics (Clinical, PoC), Research (Proteomics, Genomics, Cell), Therapeutics (Drug Delivery Wearables)], End User – Global forecast to 2030
The global Microfluidics market, valued at US$23.71 billion in 2024, stood at US$24.96 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2030, culminating in a forecasted valuation of US$37.19 billion by the end of the period. Several significant factors are driving the growth of the microfluidics market, thereby enhancing its expansion and applications. There is a growing demand for point-of-care diagnostics, which require fast, accurate, and cost-effective instruments.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Patient Access Solutions Market by Product & Service (Training, Education, Medical Necessity, Pre-certification), Delivery Mode (Web & Cloud, On premise), End User (Providers, Healthcare BPO Service Providers) - Global Forecast to 2027
The global patient access solutions market is primed to transition from $1.9 billion in 2022 to $2.9 billion by 2027, showcasing a strong CAGR of 8.9%. The factors driving market growth include the need to maintain regulatory compliance, rising need to curtail healthcare costs, rising importance of denials management. However, dearth of skilled IT professionals, and high deployment costs is challenging the growth of the global patient access solutions market to a certain extent.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Healthcare Dispensing Systems Market by Type (Automatic, Manual, Dispensing Component, Control System), Material (Reagent, Antibody, Powder), Application (Drug Delivery, Microfluidics), End User (Hospital, Pharmacy) & Region - Global Forecast to 2030
The global healthcare dispensing systems market, valued at US$4.36 billion in 2024, stood at US$4.61 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$6.27 billion by the end of the period. The market's accelerated growth trajectory is primarily driven by increasing demand for precision dispensing in pharmaceutical manufacturing, diagnostics, and medical device production.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Rich Communication Services (RCS) Market by Application (Advertising Campaign, Content Delivery, and Integrated Solutions), End-User (Consumers and Enterprises), Enterprise Size, Enterprise Vertical, and Region - Global Forecast to 2025
The global Rich Communication Services (RCS) market size is expected to grow USD 11.7 billion by 2025, at a CAGR of 17.6% during the forecasting period. Major vendors covered in the RCS market include AT&T (US), Vodafone (Uk), Deutsche Telekom (Germany), Google (US), Verizon (US), Telefonica (Spain), Orange Business (US), China Mobile (China), KDDI (Japan), Slovak Telekom (Slovakia), Telit (UK), SK Telecom (South Korea), Telstra (Australia), LG U+ (South Korea), Celcom (Malaysia), Freedom Mobile (Canada), Rogers (Canada), T-Mobile (US), O2 (UK), Telia Company (Sweden), Magyar Telekom (Hungary), Claro (Brazil), Swisscom (Switzerland), and Reliance Jio (India).
- Published: June 2020
- Price: $ 4950
- TOC Available:
-
Catheters Market by Type (Cardiovascular (Electrophysiology, Coronary Balloon, IVUS/OCT), Intravenous (CVC, PIVC, Midline), Urological, Neurovascular), Indication (Cardiac, Vascular, Kidney, Blood Transfusion, IV Medication Delivery and Fluid Management) - Global Forecast to 2030
The global catheters market, valued at US$28.51 billion in 2024, stood at US$30.53 billion in 2025 and is projected to advance at a resilient CAGR of 8.5% from 2025 to 2030, culminating in a forecasted valuation of US$45.99 billion by the end of the period.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Vendor Neutral Archives (VNA) Market by Delivery Mode (On-Premise, Hybrid), Procurement Model (Departmental, Multi-departmental), Content (DICOM, Non-DICOM), Vendor & by End User - Forecast to 2019
Medical image volumes continue to grow exponentially, and so does the complexity associated with them. Additionally, the need for sharing the information has become crucial in the healthcare IT industry in order to achieve meaningful use of the healthcare data. Traditionally, PACS served as the key information system for management of medical images. However, a major disadvantage of PACS is that it cannot interoperate across other departments in a healthcare enterprise. This resulted in the creation of data silos. The need for Vendor Neutral Archives (VNA) emerged as a result of these data silos and decoupling of archives from PACS became a logical need for healthcare organizations. The concept central to a VNA is that this interoperability is achieved through a vendor-agnostic approach, that is, the VNA acquires data from any PACS, irrespective of PACS vendor.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030
The global injectable drug delivery market, valued at US$633.77 billion in 2024, stood at US$690.23 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of US$1,034.78 billion by the end of the period. The injectable drug delivery market is driven by the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, alongside an increasing global demand for biologics.
- Published: May 2025
- Price: $ 8150
- TOC Available:
Records 31 to 40 of 50
